4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo-[3.2.2]nonane...

Details 4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo-[3.2.2]nonane... 4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo-[3.2.2]nonane...

2006-02-14

2006-02-14

Coleman, Brenda (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S221000, C540S556000

Reexamination Certificate

active

06998399

ABSTRACT:
The invention relates to compounds of the Formula I, to pharmaceutical compositions comprising them, and to the method of use thereof in the treatment or prevention of disorders associated with a dysfunction of the nicotinic receptors.

REFERENCES:
patent: 5478939 (1995-12-01), Trybulski et al.
patent: 6407095 (2002-06-01), Lochead et al.
patent: 2004/0029884 (2004-02-01), Gallet et al.
patent: 0307140 (1989-03-01), None
patent: WO 00/34279 (2000-06-01), None
patent: WO 01/92260 (2001-12-01), None

Affiliated with

Also associated with

Rating

4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo-[3.2.2]nonane... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo-[3.2.2]nonane..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo-[3.2.2]nonane... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3639269